Study describes IgG antibodies in Crohn’s disease specific for human bacterial flagellins

By | May 6, 2021
Last year, Charles O. Elson, M.D., demonstrated a potential preventive treatment for Crohn’s disease, a form of inflammatory bowel disease. He used a mouse model that included immune-reactive T cells from patients with Crohn’s disease in a flagellin peptide-specific immunotherapy.